Epidemiological and Scientific evaluation of EGFR mutation status in patients with newly diagnosed locally advanced or m - REASON

Study identifier:NIS-ODE-DUM-2009/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An NIS Registry for the Epidemiological and Scientific evaluation of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic Non-small Cell Lung Cancer (stage IIIB/IV non-small cell lung cancer)

Medical condition

Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

4243

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Sept 2009
Primary Completion Date: 01 Oct 2012
Study Completion Date: 01 Oct 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria